Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.

@article{Dahle2017AssociationBP,
  title={Association Between Pretransplant Cancer and Survival in Kidney Transplant Recipients.},
  author={Dag Olav Dahle and Tom Grotmol and Torbj{\o}rn Leivestad and Anders Hartmann and Karsten Midtvedt and Anna Varberg Reis{\ae}ter and Geir Mj{\o}en and Hege Kampen Pihlstr{\o}m and Hege Linnerud N{\ae}ss and Hallvard Holdaas},
  journal={Transplantation},
  year={2017},
  volume={101 10},
  pages={
          2599-2605
        }
}
BACKGROUND Kidney transplantation in recipients with a previous malignancy is often deferred 2 to 5 years after cancer treatment due to fear of cancer recurrence. In Norway, the required waiting period has been 1 year. METHODS We compared patient and graft survival of recipients with pretransplant cancer to the outcomes of matched recipients without such cancer (comparators) using Cox regression. RESULTS From 1963 to 2010, 377 (6.4%) of 5867 recipients had a pretransplant cancer. During a… CONTINUE READING
BETA
27
Twitter Mentions

References

Publications referenced by this paper.
SHOWING 1-10 OF 20 REFERENCES

An explanation for CEM weights. https://docs.google.com/document/d/1xQwyLt_6EXdNpA685LjmhjO20y5pZDZYwe 2qeNoI5dE/edit

G. King
  • Published March 25,
  • 2012

Similar Papers

Loading similar papers…